Enasidenib Mesylate and Hyperbilirubinemia
Result of checking the interaction of drug Enasidenib Mesylate and disease Hyperbilirubinemia for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of enasidenib may interfere with bilirubin metabolism through inhibition of UGT1A1. It is recommended to advise patients to report any changes to the color of their skin or the whites of their eyes to their healthcare provider for further evaluation. Evaluate for signs and symptoms of jaundice to rule out any conditions that may cause hyperbilirubinemia.
Generic Name: enasidenib
Brand Name: Idhifa, Idhifa
Synonyms: Enasidenib